Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
San Antonio
Biotech
MacroGenics' margetuximab nets OS gain in advanced breast cancer
MacroGenics presented new, phase 3 breast cancer data from its HER2-targeting antibody margetuximab as it works to finalize its BLA.
Conor Hale
Dec 11, 2019 10:00am
AstraZeneca, Daiichi's ADC keeps breast cancer at bay
Dec 11, 2019 8:00am
Myriad study shows cancer test can predict therapy responses
Dec 7, 2018 8:30am
